Mycophenolate mofetil 50 mg/mL oral suspension
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Mycophenolate mofetil | active | 5 g |
| Ora-Plus | suspending agent | 25 mL |
| Cherry flavor | flavor | See the study |
| Simple syrup | vehicle | q.s. to 100 mL |
- Strength
- 50 mg/mL
- Starting material
- Mycophenolate mofetil 250 mg capsules
- Container
- Amber bottle
- Potency fell below 70% by 28 days.
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 14 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
- NIOSH hazardous drug, Table 1: USP <800> handlingmycophenolate mofetil. Handle as a hazardous drug: containment primary engineering control for compounding, two pairs of chemotherapy gloves, gown, and the other USP <800> requirements. The package insert has manufacturer's special handling information.NIOSH List of Hazardous Drugs in Healthcare Settings, December 2024
Source
Fahimi F, Baniasadi S, Mortazavi SA, Dehghan H, Zarghi A. Physical and Chemical Stability of Mycophenolate Mofetil (MMF) Suspension Prepared at the Hospital. Iran J Pharm Res. 2012;11(1):171-175. PMID 24250439. PMC3813101. License: CC BY (checked 2026-11-06). Read the article
For licensed clinicians. Use with clinical judgment.